Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy Subjects
Garenoxacin (T-3811ME, BMS-284756) is a novel des-F(6) quinolone that has been shown to be effective in vitro against a wide range of clinically important pathogens, including gram-positive and gram-negative aerobes and anaerobes. This study was conducted to evaluate the safety and tolerability of m...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
2003
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC161848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12821477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.7.2256-2263.2003 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
